You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

T315i

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Needs of 3L+ CP-CML and With T315I-mutated CML Patients

Completed
  • Chronic Myeloid Leukemia
  • 3L Therapy
  • T315I
  • Lyon, France
    Novartis Investigative Site
Nov 9, 2022

3L+ Therapies Among Chronic Myeloid Leukemia and Those With

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis Investigative Site
    Nov 11, 2022

    Chronic Myeloid Leukemia Trial (Asciminib)

    Available
    • Chronic Myeloid Leukemia
    • (no location specified)
    Jan 17, 2023

    Chronic Myeloid Leukemia Trial in Worldwide (Omacetaxine mepesuccinate)

    Completed
    Has Results
    • Chronic Myeloid Leukemia
    • Omacetaxine mepesuccinate
    • Los Angeles, California
    • +31 more
    Nov 11, 2021

    Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in China (Ponatinib)

    Recruiting
    • Chronic Myeloid Leukemia
    • Acute Lymphoblastic Leukemia
    • Hefei, Anhui, China
    • +13 more
    Aug 11, 2020

    Chronic Myeloid Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in Moscow, St. Petersburg (PF-114)

    Unknown status
    • Chronic Myeloid Leukemia
    • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
    • Moscow, Russian Federation
    • +2 more
    Feb 13, 2020

    Soft Tissue Sarcoma Trial in Copenhagen (LTX-315 and TILs)

    Active, not recruiting
    • Soft Tissue Sarcoma
    • LTX-315 and TILs
    • Copenhagen, Denmark
      Herlev Hospital
    Aug 27, 2021

    Chronic Myeloid Leukemia Trial in Worldwide (ELVN-001)

    Recruiting
    • Chronic Myeloid Leukemia
    • New York, New York
    • +22 more
    Aug 15, 2022

    Chronic Myelogenous Leukemia - Chronic Phase Trial (asciminib)

    Recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • Birmingham, Alabama
    • +25 more
    Jan 10, 2023

    Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL), Ph+ Mixed Phenotype Acute Leukemia (MPAL),

    Recruiting
    • Pediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL)
    • +2 more
    • Phoenix, Arizona
    • +69 more
    Aug 23, 2022

    Cutaneous T-cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Cutaneous T-cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Sep 8, 2023

    Peripheral T Cell Lymphoma Trial in Beijing (Linperlisib in combined with Chidamide)

    Recruiting
    • Peripheral T Cell Lymphoma
    • Linperlisib in combined with Chidamide
    • Beijing, Beijing/China, China
    • +1 more
    Oct 9, 2023

    Pancreatic Ductal Adenocarcinoma, NSCLC, Colorectal Cancer Trial (AFNT-211)

    Not yet recruiting
    • Pancreatic Ductal Adenocarcinoma
    • +4 more
    • (no location specified)
    Oct 23, 2023

    Advanced Sarcoma Trial (NKG2D-CAR memory T cell)

    Not yet recruiting
    • Advanced Sarcoma
    • NKG2D-CAR memory T cell
    • (no location specified)
    Oct 17, 2023

    Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

    Not yet recruiting
    • Multiple Myeloma
    • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
    • +3 more
    • (no location specified)
    Jul 28, 2023

    HLA Typing and Tumor Neoantigen Identification forPhase I/II

    Recruiting
    • Ovarian Cancer
    • +5 more
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 27, 2022

      Class I Malocclusion Trial in Mansoura (BURSTONE T-LOOP)

      Active, not recruiting
      • Class I Malocclusion
      • BURSTONE T-LOOP
      • Mansoura, Egypt
        Mansoura University
      May 21, 2023

      Advanced Solid Tumor Trial in Beijing (aPD1-MSLN-CAR T Cells)

      Not yet recruiting
      • Advanced Solid Tumor
      • αPD1-MSLN-CAR T Cells
      • Beijing, China
        National Cancer Center Cancer Hospital Chinese Academy of Medica
      Jul 13, 2023

      Prostatic Tumors, Castration-Resistant Trial in Rotterdam (Radionuclide Therapy)

      Recruiting
      • Prostatic Neoplasms, Castration-Resistant
      • Radionuclide Therapy
      • Rotterdam, Zuid-Holland, Netherlands
        Erasmus Medical Center
      Jun 5, 2023

      Gynecologic Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Houston (Neoantigen specific TCR-T cell drug product,

      Recruiting
      • Gynecologic Cancer
      • +11 more
      • Neoantigen specific TCR-T cell drug product
      • Aldesleukin (IL-2)
      • Houston, Texas
        MD Anderson Cancer Center
      Jul 27, 2022

      T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma Trial (CD7-CART01)

      Not yet recruiting
      • T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
      • CD7-CART01
      • (no location specified)
      Sep 26, 2023

      Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

      Not yet recruiting
      • Cancer
      • +3 more
      • 177Lu-PSMA-I&T - escalating renal absorbed dose
      • 177Lu-PSMA-I&T - recommended phase 2 regime
      • (no location specified)
      Jun 14, 2023

      Child Development, Child Behavior, Social Skills Trial in New Haven (I-T CHILD)

      Active, not recruiting
      • Child Development
      • +3 more
      • I-T CHILD
      • New Haven, Connecticut
        Child care site name
      Oct 5, 2022

      Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

      Recruiting
      • Pancreas Cancer
      • +3 more
      • CAR-T cells
      • Guangzhou, Guangdong, China
        The Second Affiliated Hospital of Guangzhou Medical University
      Mar 10, 2023

      SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)

      Not yet recruiting
      • SLE (Systemic Lupus)
      • CAR T-cell therapy
      • Bangkok, Please Select, Thailand
        King Chulalongkorn Memorial Hospital
      Nov 23, 2023